Dysfunction of dopaminergic pathways in dystonia.
D000818:Animals; D001479:Basal Ganglia / Q000033:anatomy & histology / Q000502:physiology; D001931:Brain Mapping; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D004298:Dopamine / Q000172:deficiency / Q000378:metabolism*; D004421:Dystonia / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D066298:In Vitro Techniques; D009043:Motor Activity; D009415:Nerve Net / Q000002:abnormalities / Q000502:physiology; D009433:Neural Inhibition / Q000502:physiology; D009434:Neural Pathways / Q000002:abnormalities / Q000033:anatomy & histology / Q000378:metabolism; D011954:Receptors, Dopamine / Q000378:metabolism*; D014055:Tomography, Emission-Computed / Q000295:instrumentation / Q000379:methods
D011954:Receptors, Dopamine; C043437:fluorodopa F 18; D004295:Dihydroxyphenylalanine; D004298:Dopamine